More than 3 decades since its emergence in the United States, HIV continues to spread and disproportionately affect socially marginalized groups.
Preexposure prophylaxis (PrEP), a highly effective prevention strategy federally approved since 2012, could fundamentally alter the course of the epidemic. However, PrEP's potential has not been fully realized, in part because health care providers have been slow to adopt PrEP in clinical practice and have been selective in their discussion of PrEP with patients. This nonstandardized approach has constrained PrEP access. PrEP access has not only been inadequate but also inequitable, with several groups in high need showing lower rates of uptake than do their socially privileged counterparts.
Recognizing these early warning signs that current approaches to PrEP implementation could exacerbate existing HIV disparities, we call on health professionals to integrate PrEP into routine preventive health care for adult patients-particularly in primary care, reproductive health, and behavioral health settings. Drawing on the empirical literature, we present 4 arguments for why doing so would improve access and access equity, and we conclude that the benefits clearly outweigh the challenges. T he year 2012 was a landmark year in the history of HIV prevention. The US Food and Drug Administration approved the first HIV preexposure prophylactic agent for prescription: tenofovir disoproxil fumarate with emtricitabine (Truvada). This daily oral antiretroviral medication is effective in protecting HIV-negative adults from acquiring HIV 1 and is indicated for those at risk because of sexual behavior, injection practices, or both. 2 Preexposure prophylaxis (PrEP) is an important addition to the menu of prevention options offered to patients in health care settings because traditional prevention methods, such as condoms, have only partially addressed the HIV epidemic. HIV continues to spread, with transmission accelerated among certain groups in particular (e.g., Black men who have sex with men [MSM] 3,4 ). Whether used alone or combined with other prevention methods, PrEP confers numerous benefits and few known risks. Many of the benefits are unique to PrEP and cannot be obtained via other forms of protection, including its potential for covert use without a partner's knowledge, allowance of HIV-protected natural conception, dual protection against both sexual and injection risks, and dissociation from the timing of an exposure event (thus avoiding decisionmaking in the "heat of the moment" or when judgment is impaired by concurrent substance use).
Despite the immense promise of PrEP and the unique advantages it affords, many health care providers, including those aware of this recent prevention innovation, have not discussed PrEP with their patients or prescribed it. 5, 6 Providers have reported several barriers to prescribing PrEP, such as difficulty determining eligibility and time demands associated with provision and follow-up monitoring, 5, 7 but preliminary evidence suggests that these challenges may be overestimated and are often manageable in practice. 8 The slow adoption of PrEP in clinical practices has contributed to the gap between the number of people who have taken PrEP in the United States, which is around 100 000, 9 and the number at sig- 
CONTEXT AND DEFINITION
According to the 2015 US national HIV/AIDS strategy, All Americans deserve scientifically accurate, easy-to-access information about HIV transmission and prevention. This entails providing clear, specific, consistent, and scientifically up-to-date messages about risk and prevention strategies. 12(p4) Educating the US public about PrEP and other HIV prevention options is a shared responsibility among government, schools, media, and other entities. However, health care providers can play a particularly pivotal role in disseminating this information because of their medical training and capacity to immediately link individuals to prevention resources and perform associated medical monitoring.
Presently, health care providers' knowledge of PrEP and adoption of PrEP in clinical practice may be perceived as optional and discretionary. This needs to be revised in the face of strong cumulative evidence for PrEP's effectiveness across diverse populations, including MSM, heterosexual men and women, and people who inject drugs. 1 Neglecting to consistently inform patients about PrEP, especially when providing other sexual health services, may be considered suboptimal care. Routine PrEP education and provision would diminish the selection biases and missed opportunities inherent in the present nonstandardized approach.
In the health care system, routinization involves the institutionalization of clinical activities to follow an established pattern with the goal of improving medical decisionmaking and overall community health. 13 Addressing sex-and drug-related risk behavior and health needs, including HIV prevention, should be considered a health priority for all patients that cuts across medical disciplines. People at risk for HIV have reported diverse preferences for sources of PrEP information and care, including primary care physicians, infectious disease specialists, gynecologists, and psychiatrists, 14, 15 and it is incumbent on all health care providers to offer or support access to PrEP resources. Providers, particularly those practicing in primary care, reproductive health, and behavioral health settings, should be prepared to routinely perform nonjudgmental sexual health and substance use assessments and to discuss PrEP as 1 of multiple HIV prevention options available.
To maximize the quality and range of services that providers are able to offer, PrEP should be embedded in a broader, ongoing discussion of sexual and behavioral health that also incorporates sexual history and goals, other sexually transmitted infections, pregnancy, and substance use. Multiple resources are available to support providers in discussing and providing PrEP (e.g., the National LGBT Health Education Center [http://bit.ly/2vlb9UK], the Clinician Consultation Center [http://bit.ly/2gjqj68]), and technology can help minimize the time demands associated with sexual and behavioral health discussions. 16 Routinization has been an effective strategy to help normalize and promote uptake of other sexual health prevention services. For example, contraception, which was heavily stigmatized in its early days, is now more commonly discussed and offered to female patients of reproductive age regardless of their stated sexual activity and pregnancy risk. In the realm of HIV testing, moving from a client-initiated (often referred to as "voluntary") testing model, according to which HIV testing is performed by patient request, to a provider-initiated model, according to which testing is regularly offered to patients as part of standard medical care, has been shown to extend the reach of this valuable service. 17 Although both contraception and HIV testing still face some implementation difficulties and have not been routinized across all medical settings, the more commonplace provision of these services relative to earlier implementation efforts bodes well for the uptake and normalization of PrEP if integrated as a standard option within preventive health care.
Instituting a routine approach to PrEP education and provision comes with challenges, and various strategies for motivating and regulating such change will need to be explored. Health care providers and administrators will have to be educated about PrEP and perceive value in adopting a routinized approach in their clinical practices. Securing approval and formal endorsement from medical authorities and revising clinical guidance to reflect this recommendation may help promote buy-in. Enhancing the visibility of health care settings that have successfully adopted a routinized model of PrEP education and provision could demonstrate feasibility and help cultivate new norms that encourage similar institutions to follow suit. 6 Linking discussion of PrEP to services that are already being routinely provided in a certain setting, such as HIV testing, is a logical pairing that may facilitate implementation of a routinized approach to PrEP.
Structural initiatives could also be considered as a means of ensuring routine PrEP education; for example, existing state laws that mandate offering HIV testing to patients could be amended to also require PrEP counseling for those who test negative. Although there are certain to be obstacles to routinizing PrEP in preventive care, the potential public health benefits of a more equitable and effective approach to implementing PrEP are substantial, realistic, and worthy of additional investment.
HOW ROUTINIZATION IMPROVES ACCESS AND EQUITY
We draw on the empirical literature to present 4 arguments for integrating PrEP into routine preventive health care, highlighting the mechanisms by which a routinized approach to PrEP discussion and provision would improve access and avoid exacerbating existing HIV disparities (Table 1 provides a summary). Of note, we have anticipated criticisms of this approach involving concerns about cost-effectiveness, provider time constraints, side effects and safety, and impact on other sexually transmitted infections. Appendix A (available as a supplement to the online version of this article at http://www. ajph.org) provides a summary and counterarguments of these anticipated criticisms.
Avoids Missing Potential Candidates
Individuals at risk for HIV are not easily identifiable. HIV risk is unlike many other medical conditions or health concerns that providers routinely diagnose on the basis of direct observation of symptoms. Although a minority of patients at risk for HIV have clinical signs of recent condomless sex or injection drug use (e.g., pregnancy, other sexually transmitted infections, needle marks) that may cue providers to possible HIV risk, many patients do not. Thus, "diagnosis" of HIV risk relies heavily on secondhand information obtained through patient self-report. Patients may not accurately disclose the extent to which they are consistently using condoms, clean needles, and other methods of protection and whether they consider these methods to be acceptable for multiple reasons, including discomfort with sharing sensitive information and fear of provider judgment. MSM-and Black MSM in particular 18 -may be uncomfortable disclosing their same-sex sexual behavior to providers because of anticipated or internalized heterosexism (i.e., negative attitudes toward sexual minorities). Additionally, if patients are unaware that a provider is conditioning PrEP education and access on their disclosure of relevant risk behavior, they may lack incentive to disclose such behavior.
Even if patients were fully forthcoming about their sexual histories and goals, providers broaching PrEP only with patients they judge to be at substantial risk for HIV is problematic because risk prediction is an imperfect process. The US Public Health Service 2 and other health authorities have published clinical guidelines containing eligibility criteria to help determine HIV risk and PrEP candidacy, but these criteria are not sensitive to all patients who stand to benefit from PrEP. Therefore, if providers use these criteria to identify patients with whom to discuss PrEP, some PrEP candidates will be missed. In 1 longitudinal study, 19 only 65% of Black MSM who seroconverted would have met US Public Health Service criteria for PrEP at the previous study time point. If PrEP is only discussed with patients who providers perceive to be at risk, some at-risk patients will not be recognized and will not be informed about PrEP even though they could benefit from it Eligibility criteria put forward by the US Public Health Service and other authorities are not sensitive enough to identify all patients at risk for HIV Absent a routinized approach, decisions about whom to discuss PrEP with will be vulnerable to social biases Providers failing to discuss PrEP with patients who could benefit from its use is particularly Notably, 88% of White MSM who seroconverted in this same study would have met criteria. 19 Cross-sectional survey research has revealed a similar disparity, reporting sexually active Black MSM to be less likely than their White and Hispanic counterparts to meet PrEP eligibility criteria. 20 These data raise concern that current clinical criteria may not only miss PrEP candidates, but miss Black PrEP candidates in particular.
Racial disparities in PrEP eligibility according to preestablished criteria may reflect the failure of such criteria to sufficiently capture the social and structural risk factors driving the HIV epidemic in the Black community and driving HIV disparities 19, 20 ; for example, because people tend to choose sexual partners of the same race and the HIV prevalence among Black MSM is disproportionately high, 3 In the absence of a routinized approach to PrEP education, whereby all adult patients receive at least basic information about PrEP, a provider's decision about whether to inform a patient about PrEP is likely to be governed by both perception of the patient's HIV risk and the projected impact of PrEP on the patient's health. Assessment of this impact may include judgments about the patient's likelihood of adhering to a PrEP regimen and the likelihood of using other risk reduction strategies (e.g., condoms) concomitantly as encouraged in PrEP clinical guidance. 2 Previous survey research with medical students suggests that clinical decision-making related to PrEP -including assumptions about patient behavior while taking PrEP and consequent intention to prescribe PrEP to a patientmay be vulnerable to biases related to patient race and sexual orientation. 11, 21 For example, when presented with a clinical vignette about a hypothetical MSM patient seeking a prescription for PrEP, medical students judged the patient as being more likely to increase condomless sex if prescribed PrEP when they were told he was Black as opposed to White; anticipated increase in condomless sex was associated with lower intention to prescribe PrEP to the hypothetical patient. 11 Such social biases are especially problematic because of the current epidemiology of HIV, according to which Blacks, MSM, and Black MSM specifically are disproportionately affected. 3 Failure to routinely educate and offer PrEP to patients allows providers' personal biaseswhether conscious or not-to govern patient information and access to PrEP. Finally, it is worth noting that providers neglecting to raise the topic of PrEP with at-risk patients is of particular concern because many such individuals are still unaware of PrEP 22 and are hence dependent on their providers to introduce the topic. In some communities, awareness may be especially limited among racial and ethnic minority groups in which HIV incidence is disproportionately high. 22 Presently, PrEP is perceived by many as a medication specific to gay men and an indicator of promiscuity. [25] [26] [27] [28] Both associations may discourage PrEP candidates from seeking PrEP, as they may fear being judged or "outed" by providers, peers, and others or wrongly assume that they are ineligible. 14, 27, 28 Such assumptions may also dissuade them from initiating PrEP when recommended by a provider. Research, public health, and media discourse on PrEP has largely focused on PrEP for MSM because of this population's disproportionate risk for HIV relative to other social groups. An inadvertent consequence of this focus has been cultivation of the perception that PrEP is a medication specific to MSM, which may operate as a deterrent to PrEP use for people at risk for HIV who are not MSM (e.g., women 14, 29 ) and to MSM who wish to maintain privacy about their same-sex sexual orientation. 25, 27 Early research suggests that Black and Latino MSM perceive greater stigma about PrEP than do their White counterparts in some communities 30 and have greater concern about people noticing and making assumptions about their PrEP use than do other MSM. 23 Thus, the destigmatization of PrEP is particularly essential for encouraging PrEP access among racial and ethnic minority MSM. Integrating PrEP into routine preventive care by discussing it with all patients and providing it to those who elect to use it would help reframe it as medication appropriate for sexually active individuals irrespective of sexual orientation or partner sex, consistent with its indication.
PrEP stigma affects demand by potential candidates and supply by health care providers. With the current nonroutinized approach, providers who are familiar with stereotypes of PrEP users as gay, exceptionally risky, or both may fail to recognize PrEP candidates who do not fit these preconceptions on the basis of their gender or self-presentation. At the same time, providers may be reluctant to broach the topic of PrEP with patients belonging to stereotyped groups for fear of offending them by insinuating stereotypical assumptions.
In addition to removing PrEP stigma as a barrier to both patients' seeking and providers' prescribing PrEP, routinizing conversations about PrEP would help destigmatize it in the eyes of the general public. This may influence public support for policies and programs that make PrEP affordable for many patients and improve access for racial and sexual minorities in particular. 31 
Facilitates PatientCentered Care
A patient-centered model of care aligns with the values put forward by the Institute of Medicine, 32 the American Medical Association, 33 and other professional organizations dictating medical codes of conduct. Providers should present PrEP as a preventive option and support patients in making an informed decision about whether it fits with their sexual experiences and goals. Routinely discussing PrEP with patients could help alleviate the pressure or discomfort providers experience when deciding PrEP eligibility by making it a shared endeavor with their patients. Some providers have anticipated difficulty identifying PrEP candidates to be a potential barrier to PrEP provision, in part because they perceive many providers to lack the skills needed to effectively communicate about sexual health with patients. 7 With discussion of PrEP left to provider discretion, this difficulty could serve as a barrier to even broaching the topic. Providers may feel less intimidated by the prospect of determining a patient's PrEP eligibility if they routinely engage patients in shared decisions about PrEP, similar to contraception decision-making, as opposed to having to decide alone whether to initiate a conversation about PrEP. Patients possess significantly greater insight into their sexual histories and intentions than do their providers, even when they are fully forthcoming in sexual health discussions. Thus, patients can offer complementary expertise to providers' medical knowledge when approaching PrEP decisionmaking. Failing to broach the topic with a patient constitutes onesided decision-making on the basis of incomplete data.
If educating patients about PrEP was routinized, providers may be motivated to seek skills-based training on discussing sex with patients and could build competence and confidence in this area by way of experience. Recent survey research suggests that 1 in 4 primary care providers are not comfortable discussing sexual activities with their patients 5 and that clinicians tend to overestimate patients' sensitivity to questions about sexual orientation. 34 20, 35 suggests a correlation between the decision to use PrEP and need for PrEP. PrEP-seeking patients who perceive themselves to be at risk for HIV despite minimal risk taking, sometimes pejoratively labeled the "worried well," are uncommon; however, even these individuals may derive benefit from PrEP (e.g., reduced anxiety). 36 Discussing PrEP and other aspects of sexual health with patients at low perceived risk or who ultimately decline PrEP is not a wasted effort, as an individual's sexual risk taking often fluctuates over time and PrEP may be a desirable option in the future. Additionally, patients' readiness to initiate PrEP may evolve over time, 37 so it is preferable to introduce PrEP as early as possible regardless of likely uptake at first introduction.
Transmits Knowledge to the Broader Community
Awareness of PrEP has been slow to permeate the US general public, including subgroups at disproportionately high HIV risk. For example, in a study of HIVuninfected, sexually active Black MSM in Atlanta, Georgia, 38 less than a quarter were aware of PrEP, and no significant increase in awareness occurred between 2012 (before US Food and Drug Administration approval) and 2014, nearly 2 years after US Food and Drug Administration approval. Women at high risk for HIV have expressed anger over not being informed about PrEP sooner 14, 29 and concern about their health care providers being uninformed about PrEP.
14 Low awareness and misconceptions about PrEP, including the notion that it is indicated exclusively for MSM, may be corrected by providers, and this knowledge may in turn help remedy unawareness and misinformation in the community.
Medical mistrust has been identified as a potential deterrent to PrEP uptake, particularly among Black MSM. 39 Individuals with high levels of medical mistrust are unlikely to seek medical services and will consequently lack the opportunity to receive education about PrEP directly from a medical provider. 
CONCLUSIONS
It is an ethical imperative for health care providers to offer PrEP to those who might benefit and for other health professionals to implement standards and systems that would support the routine discussion and provision of PrEP in health settings. Although some may have reservations about a routinized approach, we argue that these concerns are outweighed by the numerous benefits PrEP offers (Appendix A). Presently, PrEP education and provision being optional and selective unfairly restricts access for many individuals. Moreover, it systematically disadvantages Black MSM and other populations who stand to benefit the most from PrEP and has the potential to widen HIV disparities. Routinization helps circumvent factors that may limit access for these priority populations, such as provider bias and patient nondisclosure.
Preliminary signs of disproportionately low national PrEP uptake among Blacks versus Whites in general, 40 and among Black MSM versus White MSM in particular, 20 demand immediate action to remedy inequities in PrEP education and access. Making PrEP a standard component of preventive health care for all patients would be a significant step that health professionals could take in this direction. Additionally, professional organizations and other authorities that establish standards of practice should strongly consider endorsing this approach in clinical guidelines and training curricula. Setting the expectation that PrEP should be an integral part of routine preventive care could stimulate more frequent discussions about PrEP, more effective use of PrEP, and more equitable access to PrEP, which could decrease HIV incidence and avoid worsening HIV disparities. K. H. M. is a senior member of the faculty and advisory board of the National LGBT Health Education Center and an associate editor and contributor to educational materials provided through the organization's Web site, to which readers of this article are referred. S. K. C. and D. S. K. have contributed to these educational materials as well. All 3 authors have received compensation for their efforts in developing or delivering medical education related to preexposure prophylaxis.
Note. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the NIMH or the NIH.
HUMAN PARTICIPANT PROTECTION
Institutional review board approval was not needed because this analytic essay does not present an original research study involving human participants.
